Gibson Christopher bought RXRX
August 11, 2025 · Form 4 insider transaction
Gibson Christopher bought 17,875 shares of Recursion Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as conversion of a derivative under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,875
Price
$0.00
Total value
N/A
InsiderGibson Christopher
Role—
SecurityClass A Common Stock
Transaction codeC: Conversion of a derivative
Transaction dateAugust 11, 2025
Filing dateAugust 13, 2025
Shares owned after17,875
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
Represents the automatic conversion of Class B Common Stock into Class A Common Stock.; This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.; The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.